Although patients receiving lipid-lowering treatment showed a trend of improved survival rates ( Supplementary Table S2 ), this association did not reach statistical significance after adjusting for other covariates (Model 1: HR = 0.61 (95% CI: 0.37–1.01), Model 2: HR = 0.65 (95% CI: 0.38–1.10), Model 3: HR = 0.65 (95% CI: 0.38–1.10), Supplementary Tables S3 – S5 ).
← all excerpts
Prognostic value of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) in patients with RAS-mutant metastatic colorectal cancer.
1
—
—